Comparing tumor antigen specificity of lysate versus peptide-pulsed dendritic cell-based vaccines

被引：0
|
作者：
Maine, GN [1 ]
Mulé, JJ [1 ]
机构：
[1] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A334 / A334
页数：1
相关论文
共 50 条
  • [1] Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein
    Shimizu, K
    Thomas, EK
    Giedlin, M
    Mulé, JJ
    CANCER RESEARCH, 2001, 61 (06) : 2618 - 2624
  • [2] Peptide-pulsed dendritic cell vaccines; Autologous or allogeneic dendritic cells?
    Merrick, Alison
    Diaz, Rosa
    Vile, Richard
    Melcher, Alan
    CLINICAL IMMUNOLOGY, 2006, 119 : S151 - S151
  • [3] Dendritic cell-based tumor vaccines and antigen presentation attenuators
    Evel-Kabler, Kevin
    Chen, Si-Yi
    MOLECULAR THERAPY, 2006, 13 (05) : 850 - 858
  • [4] A High-Affinity T-Helper Epitope Enhances Peptide-Pulsed Dendritic Cell-Based Vaccine
    Li, Ang
    Xiong, Sidong
    Lin, Yi
    Liu, Rongjun
    Chu, Yiwei
    DNA AND CELL BIOLOGY, 2011, 30 (11) : 883 - 892
  • [5] Immunotherapy of cancer with dendritic cell-based tumor vaccines
    Gilboa, E
    Nair, SK
    Boczkowski, D
    Mitchel, D
    Faiola, B
    CANCER GENE THERAPY, 1997, 4 (05) : 314 - 314
  • [6] Zoledronate-pulsed dendritic cell-based anticancer vaccines
    Kamigaki, Takashi
    Takahara, Masashi
    Maekawa, Ryuji
    Goto, Shigenori
    ONCOIMMUNOLOGY, 2013, 2 (09)
  • [7] Advances in dendritic cell-based therapeutic tumor vaccines
    Qin, Simin
    Na, Jintong
    Yang, Qun
    Tang, Jing
    Deng, Yamin
    Zhong, Liping
    MOLECULAR IMMUNOLOGY, 2025, 181 : 113 - 128
  • [8] Immunotherapy of cancer with dendritic cell-based tumor vaccines
    Gilboa, E
    Nair, SK
    Morse, M
    Boczkowski, D
    Deng, Y
    Lyerly, HK
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [9] Potency analysis of peptide, lysate and apoptotic cells as sources of tumor antigen(s) in dendritic cell-based vaccine immunotherapy in vivo.
    Shimizu, K
    Kotera, Y
    Mulé, JJ
    FASEB JOURNAL, 2001, 15 (05): : A1207 - A1207
  • [10] Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12
    Fallarino, F
    Uyttenhove, C
    Boon, T
    Gajewski, TF
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (02) : 324 - 333
12345